Clinical Trial Search

Primary: Drinking — 6; 8; 2 participants — p=<0.04

Primary: Weekly Percentage of Heavy Drinking Days — 37.9; 48.4 percentage of heavy drinking days

Primary: Percentage of Screen Eligible Who Enroll — 28; 5 Participants

Primary: Heavy Drinking Days Per Week — 0.23; 0.33 days/week

Primary: Rate of Heavy Drinking Days Per Week. — .89; 1.21 rate of heavy drinking days per week — p=0.10

Primary: Percentage of Heavy Drinking Days During the Last 8 Weeks of Treatment — 2.07; 2.25 log transformed percentage of days

Primary: Weekly Percentage of Heaving Drinking Days — 37.6; 31.3 weekly percentage of heavy drinking days

Primary: "Drinking Days" in the Previous Month — 19.54; 15.18; 17.75; 22.11 Days — p=<0.001

Primary: Treatment Engagement — 36; 9 percentage of participants engaged

Primary: Change From Baseline in the Monthly Number of Heavy Drinking Days (HDDs) — -10.58; -12.30 days — p=0.012

Primary: Change From Baseline in the Monthly Number of Heavy Drinking Days (HDDs) — -8.91; -11.24 days — p=0.002

Primary: Drinks Per Drinking Day — 8.7; 8.9; 9.2 Drinks per drinking day

Primary: Visual Analog Scales of Similarity to Alcohol - Baseline — 0; 0; 0; 0 units on a scale

Primary: Percent Heavy Drinking Days — 37.1; 37.9 percentage of heavy drinking days

Primary: Change in Number of Heavy Drinking Days (i.e., 5 or More Drinks Per Day for Men, and 4 or More Per Day for Women)Per Week, by Week — -.30; -.20 Days/week — p=.012

Primary: Percentage of Heavy Drinking Days at Week 16 Endpoint — -43.02; -38.72 percentage of days — p=0.120

Primary: The Weekly Mean Number of Standard Drinks Consumed Per Day at Baseline and Treatment Phase — -6.7 Standard Drinks — p=<0.0003

Primary: Craving for Alcohol in Alcohol Dependence With Citalopram Compared to Placebo — 21; 30.4; 10.8; 10.6 score on a scale

Primary: Level of Intoxication (Subjective Response) on Each Condition Day After Drinking Relative to How They Felt When Arriving to the Lab on That Respective Day )Prior to…

Primary: Alcohol Consumption (Percentage of Heavy Drinking Days) — 70.2; 58.4; 20.2; 14.7 percentage of heavy drinking days

Primary: Use of Alcohol — 15; 8 participants

Primary: Change From Baseline in Drinking Quantity and Frequency Using Drinks Per Week at Week 12 — 42.07; 56.67; 41.20; 9.16 drinks/week

Primary: Alcohol Consumption — 71.8; 66.5; 11.4; 22.6 percentage of days heavy drinking

Primary: Number of Patients With Adverse Events (AEs) — 103; 377; 8; 35 participants

Primary: Visual Analog Scale of Craving to Drink at 1 Week Following Administration of Fenofibrate or Placebo During the Double-Blind Period — 8.94; 10.37; 9.83; 11.03 units on a…

Primary: Biphasic Alcohol Effects Scale (BAES): Stimulant Subscale — 13.756; 14.053; 13.026 score on a scale — p=0.867

Primary: Percent Subjects Completely Abstinent — 44; 19; 33; 71 percent of participants — p=0.03

Primary: Intervention Effects on Brain Functional Connectivity — 0.05; 0.19 percentage of Blood Oxygenation Level De

Primary: Alcohol Consumption — 92.0; 77.3 mg/%

Primary: Treatment Adherence — 15 Participants